PharVision Advisers’s LZ Technology Holdings LZMH Stock Holding History

PharVision Advisers’s Portfolio LZMH Stock Details LZMH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-879	Closed	-$57.8K	–	1057
2025 Q3	$57.8K	Buy	+879	New	+$87.3K	0.03%	647

Other funds holding LZMH

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

PharVision Advisers's LZMH Position: Q4 2025 in Review

PharVision Advisers sold out of LZ Technology Holdings (LZMH) in Q4 2025, closing a stake of 879 shares — an estimated $57.8K sold.

PharVision Advisers first reported a position in LZMH in Q3 2025 and held it in 1 quarter. The position peaked at $57.8K in Q3 2025. 9 funds tracked by Wall St. Rank hold LZMH as of Q4 2025.

PharVision Advisers reported no remaining LZ Technology Holdings position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 879 LZ Technology Holdings shares in Q4 2025, an estimated $57.8K.
PharVision Advisers first reported a position in LZ Technology Holdings in Q3 2025 and held it in 1 quarter.
PharVision Advisers's LZ Technology Holdings position peaked at $57.8K in Q3 2025.
9 funds tracked by Wall St. Rank held LZ Technology Holdings as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.